Why This Five-Star Analyst Is Bullish on IBM Stock
As big AI companies face pressure over high prices and slowing demand, investors are starting to look at less-hyped tech stocks for growth opportunities. As a result, IBM has been gaining attention as it works on a turnaround plan. In fact, its stock is up 19% so far this year. Furthermore, five-star Bank of America analyst Wamsi Mohan recently told CNBC that he thinks IBM can meet its goals.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Indeed, Mohan pointed out that IBM has sold off the parts of its business that weren't growing and put money into areas that are. And while some investors are unsure whether or not IBM can hit its target of over 5% growth this year, especially since last quarter only saw 2% growth, Mohan thinks it is possible. He said this could happen thanks to a new mainframe product launch, which remains more important to IBM's business than many people realize. Because of these changes, Mohan said he is 'very bullish' on IBM.
It is also worth noting that IBM has been getting a boost from its AI business, as its AI products and services passed $5 billion in total bookings by the end of Q4, with $2 billion added just last quarter. In addition, IBM made its Granite AI models for businesses much cheaper to run last year and about 90% more efficient than larger models. Moreover, the company is seeing growing interest in its Red Hat-based AI platforms, including RHEL AI, OpenShift AI, and watsonx, which are helping move its AI strategy forward.
What Is the Target Price for IBM?
Turning to Wall Street, analysts have a Moderate Buy consensus rating on IBM stock based on eight Buys, five Holds, and two Sells assigned in the past three months, as indicated by the graphic below. Furthermore, the average IBM price target of $260.62 per share implies 0.9% upside potential.
See more IBM analyst ratings
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
15 minutes ago
- Globe and Mail
Building on a strong foundation: Solmax launches Performance Materials
, /CNW/ -- Solmax is proud to announce the launch of their new Performance Materials platform, the next chapter in the integration of a long-standing legacy of TenCate Geosynthetics and Propex, now operating as a division of Solmax. For decades, both TenCate Geosynthetics and Propex built an Industrial Fabrics reputation next to their Geosynthetics activities with innovative, durable, and reliable solutions for the agricultural, recreational, and specialty markets. That commitment remains unchanged. As Performance Materials, the company carries forward the same trusted products, the same technical expertise, and the same customer-first philosophy – now with even greater global reach, resources, and opportunities through Solmax. Performance Materials provides high-performance solutions that support agriculture, recreation, and specialty industries. The company brings deep technical knowledge, practical innovation, and a hands-on approach to solving real-world challenges – helping customers work smarter, protect essential resources, and thrive in a changing world. "Performance Materials builds on a proud legacy of delivering practical, reliable solutions," said Bob Gilligan , CEO of Solmax. "We are investing in the future of technical textiles, strengthening our offering for the agriculture, recreation, and specialty markets while staying true to the values that earned our customers' trust." Backed by Solmax's global strength, Performance Materials is ready to take this legacy forward – with the same reliability, innovation, and partnership you've always counted on. Explore the new website and discover how Performance Materials is building on a proud history and shaping a strong future. Visit the website to learn more about Performance Material's products and solutions. About Performance Materials Performance Materials, a division of Solmax, delivers high-performance industrial fabrics for agriculture, recreation, and specialty markets. With decades of specialized expertise, we engineer durable, tested solutions designed to reduce waste, protect resources, and boost operational efficiency. Our materials serve a wide range of applications: from crop protection and containment to filtration, shade, and transportation, adapting to evolving customer needs and environmental demands. Grounded in technical know-how and driven by partnership, we go beyond supplying products. We solve problems. Performance Materials is committed to building safer, resilient and long-lasting solutions.
Globe and Mail
an hour ago
- Globe and Mail
These 3 Passive-Income ETFs Are a Retiree's Best Friend
Most people don't want to spend much time managing their retirement portfolio once they've stopped working. After all, you've made it! This is the period in your life when it's time to relax. It is essential to know the tools available to help you build a diversified nest egg that will meet your needs without having to watch it 24/7. That's where exchange-traded funds (ETFs) can help. These are buckets of stocks that trade under one ticker symbol. An ETF might follow an index or a particular investment strategy. The great thing is that a small handful of ETFs can create a well-diversified portfolio that will help protect you from risk. Here are three ETFs that could be a retiree's best friend. They are different from one another, but all three offer retirees the passive income they need. 1. Vanguard International High Dividend Yield ETF America is home to many of the world's most prominent companies, which is why the U.S. stock market is more valuable than any other countries' by a wide margin. However, there are still remarkable companies outside the United States that can help your portfolio. The Vanguard International High Dividend Yield ETF (NASDAQ: VYMI) is a great way to add that international investment exposure without having to wade through data that could be in different currencies or languages. It's the perfect situation for an ETF. It carries a 0.22% expense ratio, which Vanguard claims is far lower than comparable funds. VYMI Dividend Yield data by YCharts The ETF holds nearly 1,500 stocks, primarily companies based in North America, Europe, the Pacific region, and emerging markets. Its holdings span virtually all industries and includes top holdings like Nestle, Novartis, Roche, and Shell. The ETF's current yield is approximately 4.6%. Since its inception in 2016, the ETF has generated annualized total returns averaging 8.3%. Consider the Vanguard International High Dividend Yield ETF a great ETF for investing in fantastic companies that probably wouldn't be on your radar otherwise. 2. Invesco High Yield Equity Dividend Achievers ETF The passive income doesn't stop there. The Invesco High Yield Equity Dividend Achievers ETF (NASDAQ: PEY) tracks an index of 51 stocks on the Nasdaq stock exchange with high yields and a history of dividend growth. Financial and utility stocks comprise roughly half the ETF, which lists Walgreens Boots Alliance, Altria, Franklin Resources, Verizon Communications, and UGI among its largest holdings. No stock represents more than 4% of the ETF, so it's well-diversified despite holding just 51 stocks. PEY Dividend Yield data by YCharts This ETF's expense ratio is 0.53%, a little higher than I generally like. However, it has averaged a 9.5% annualized return (pre-tax) over the past decade, giving investors solid total returns while meeting their passive income needs. Invesco High Yield Equity Dividend Achievers ETF currently yields 4.6%. The fund's market price has climbed amid the Federal Reserve's interest rate cuts, which underlines how attractive these reliable high-yield ETFs can be to investors in a lower-rate investing climate. 3. Invesco S&P 500 High Dividend Low Volatility ETF Peace of mind is increasingly important as you age, which attracted me to the Invesco S&P 500 High Dividend Low Volatility ETF (NYSEMKT: SPHD). This ETF holds 52 companies listed on the S&P 500 index with high dividend yields and low betas. Stocks with high dividend yields can be more volatile because high yields can signal underlying trouble in a company. However, these low-beta stocks are the exception to this common wisdom. They generally stay more grounded and don't go up or down as sharply as the broader market. SPHD Dividend Yield data by YCharts Its top holdings include Bristol Myers Squibb, Altria, Kinder Morgan, AT&T, and Dominion Energy. Once again, the ETF holds a modest number of stocks (52), but the largest weighting is just over 3%. It's all spread pretty evenly, which means the ETF is well-diversified. The fund's yield is just 3.4%, following strong performance over the past 12 months. The ETF's annualized total returns have averaged 10% for the past decade, a pretty good deal considering the expense ratio is just 0.30%. Those looking for an ETF of mature blue chip dividend stocks should take a good look here. Should you invest $1,000 in Vanguard International High Dividend Yield ETF right now? Before you buy stock in Vanguard International High Dividend Yield ETF, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vanguard International High Dividend Yield ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. See the 10 stocks » *Stock Advisor returns as of November 11, 2024 Justin Pope has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Bristol Myers Squibb and Kinder Morgan. The Motley Fool recommends Dominion Energy, Nestlé, Roche Holding AG, and Verizon Communications. The Motley Fool has a disclosure policy.
Globe and Mail
an hour ago
- Globe and Mail
UnitedHealth (UNH) CEO Hemsley Vows Cost Controls as Q1 Earnings Fall Short
UnitedHealth's (UNH) new CEO, Steve Hemsley, opened his tenure by apologizing for the company's first earnings miss since 2008, pledging to restore shareholder confidence and address rising care costs. Hemsley replaced Andrew Witty after the first-quarter shortfall, which was driven by unexpectedly high costs in the Medicare Advantage unit, prompting a suspension of the 2025 guidance as UnitedHealth recalibrated its financial outlook. Market Overview: UnitedHealth missed first-quarter earnings estimates for the first time since 2008 Medicare Advantage costs rose above forecast, leading to suspension of 2025 guidance Optum Rx pharmacy benefit manager and UnitedHealthcare insurer units faced higher-than-expected care costs Key Points: Hemsley committed to incorporating elevated care-cost assumptions into future pricing Company will review forecasting models and risk metrics across all business units Optum Rx and UnitedHealthcare divisions to undergo a comprehensive audit of practices Looking Ahead: Investors will watch for more accurate guidance tied to real medical-cost trends Execution of cost-control measures and transparent reporting will be critical to restoring confidence Containment of Medicare Advantage losses will determine near-term profitability and trust Bull Case: The return of Stephen Hemsley as CEO brings experienced leadership to UnitedHealth. Hemsley previously led the company from 2006 to 2017 and has a deep understanding of its operations. He has pledged to earn back shareholder trust and optimize quality in its health services. Hemsley has initiated a comprehensive review of all company policies, practices, and performance measures, including controversial areas like Medicare Advantage risk adjustment and pharmacy benefits management. This review will involve independent experts, and approaches will be modified where appropriate. The company plans to factor in higher care costs into its private insurance plans and next year's Medicare Advantage plans, which could help stabilize margins in the future. Despite recent setbacks, UnitedHealth has a history of resilience and delivering long-term value to shareholders, as evidenced by a total shareholder return of nearly 16% over the past five years. Hemsley expressed optimism about the company's future, stating that many of the issues are within UnitedHealth's control and capacity to resolve. Bear Case: UnitedHealth reported its first earnings miss since 2008 in the first quarter, driven by unexpectedly high medical costs in its Medicare Advantage unit, leading to a suspension of its 2025 financial outlook. The company's shares plummeted significantly following the earnings miss and guidance withdrawal, reflecting a sharp decline in investor confidence. Shares fell nearly 20% in pre-market trading after the initial Q1 earnings report and later hit their lowest closing price since October 2020. Rising care utilization, particularly in Medicare Advantage where physician and outpatient care activity was described as "twice the rate we anticipated," is a major challenge, straining medical costs and profitability. The Optum Health division faced reimbursement gaps due to members transitioning from exited plans who required costlier care than expected. The abrupt departure of former CEO Andrew Witty and the suspension of guidance less than a month after a previous downgrade indicate significant internal challenges and uncertainty regarding the company's financial trajectory. UnitedHealth faces reputational challenges and scrutiny over various practices, which new CEO Hemsley has acknowledged and pledged to review. Hemsley emphasized that future financial guidance would explicitly reflect rising care costs and that all segments must improve forecasting accuracy to rebuild trust. Analysts noted that UnitedHealth must demonstrate tangible progress in cost containment and deliver consistent, reliable forecasts to stabilize its stock and regain investor confidence.
